Literature DB >> 9800164

Sonographic findings in methamphetamine-induced ischemic colitis.

C A Dirkx1, E O Gerscovich.   

Abstract

Ischemic colitis is a clinicopathologic condition that commonly occurs in elderly patients with atherosclerotic disease or diabetes mellitus. Uncommon etiologies include vasculitis and use of drugs such as oral contraceptives, phenobarbital, nasal decongestants, dextroamphetamine, and cocaine. Recent studies have shown sonography and CT to be helpful in the evaluation of the colitides. We report the sonographic and CT findings in an unusual case of methamphetamine-induced ischemic colitis. Sonography and CT revealed diffuse thickening of the large bowel wall. Methamphetamine abuse should be considered in the differential diagnosis of the colitides, particularly in the setting of a young patient with a history of drug use and no other predisposing conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800164     DOI: 10.1002/(sici)1097-0096(199811/12)26:9<479::aid-jcu9>3.0.co;2-k

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  4 in total

1.  Methamphetamine-associated shock with intestinal infarction.

Authors:  Temple A Brannan; Suganthi Soundararajan; Bruce L Houghton
Journal:  MedGenMed       Date:  2004-12-29

2.  A fatal case of amphetamine induced ischaemic colitis.

Authors:  P A Green; Clf Battersby; R M Heath; L McCrossan
Journal:  Ann R Coll Surg Engl       Date:  2017-09       Impact factor: 1.891

3.  Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats.

Authors:  Amanda L Persons; Brinda D Bradaric; Hemraj B Dodiya; Michael Ohene-Nyako; Christopher B Forsyth; Ali Keshavarzian; Maliha Shaikh; T Celeste Napier
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

4.  Altered fecal microbiota composition in individuals who abuse methamphetamine.

Authors:  Yongde Yang; Xuan Yu; Xuebing Liu; Guangya Liu; Kuan Zeng; Gang Wang
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.